Abivax Announces Presentation Of Late-Breaking Abstract For Obefazimod From Abtect Phase 3 Induction Trials At 2025 UEG Meeting

Refinitiv阅读少于1分钟

Abivax SA ABVX:

ABIVAX ANNOUNCES PRESENTATION OF LATE-BREAKING ABSTRACT FOR OBEFAZIMOD FROM THE ABTECT PHASE 3 INDUCTION TRIALS AT 2025 UNITED EUROPEAN GASTROENTEROLOGY (UEG) MEETING

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

登录或创建永久免费帐户以阅读此新闻